TH
Thomas Haughey
Director

Thomas Haughey insider trades: Ani Pharmaceuticals (ANIP) stock buys and sales

Director, Ani Pharmaceuticals Last trade Jun 8, 2026 44 Form 4 filings
$162K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2007
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 8, 2026ANIP↓ Sell$162K
Aug 12, 2025ANIP↓ Sell$1.7M
Dec 6, 2021ANIP↑ Buy$98K
Mar 4, 2020ANIP↑ Buy$226K
May 15, 2019ANIP↑ Buy$173K
May 10, 2011PRX↓ Sell$953K
May 9, 2011PRX↓ Sell$3.7M
Mar 2, 2010PRX↓ Sell$1.1M
Aug 25, 2009PRX↓ Sell$632K
Oct 17, 2008PRX↑ Buy$16K
Oct 17, 2008PRX↑ Buy$9K
Oct 3, 2007PRX↑ Buy$45K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANIP insiders

Open-market trades in the last 12 months

About Thomas Haughey's insider trades

Thomas Haughey is a director at Ani Pharmaceuticals (ANIP). Since Oct 3, 2007, Thomas has reported 6 open-market purchases worth $568K and 6 sales worth $8.2M on SEC Form 4. In the last 12 months: 1 sale ($162K).

Their filings also include grants and awards (19 filings), shares withheld for taxes (17 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.